In this randomized controlled trial, fidanacogene elaparovovec therapy significantly reduced the mean annualized rate of ...

Traws Pharma, Inc. (NASDAQ: TRAW) has announced promising topline results from its Phase 1 study of tivoxavir marboxil, an ...

Researchers at Johns Hopkins found that widespread early use of convalescent plasma during the first year of the COVID-19 ...

Boron powder can be used to shield tokamak walls from the extreme heat of fusion, presenting a solid strategy for sustainable ...

Investigational agent in development as a one dose treatment or prevention of seasonal and pandemic influenzaA dose ranging, Phase 1 study in ...

Seeking to improve the tokamak fusion reactor known as ITER, researchers have found a way to stop rogue tungsten atoms from ...

In a study published in the ExRNA journal, researchers from the Novosibirsk Institute of Chemical Biology and Fundamental ...

Fusion researchers are increasingly turning to the element tungsten when looking for an ideal material for components that ...

Prolytix Introduces Groundbreaking Technique for Plasma and Multi-Tissue Matrix Measurement.New York, USA - October 5, 2024 — Prolytix, a ...

A new study led by researchers at Johns Hopkins Bloomberg School of Public Health estimates that thousands of lives could have been saved during the first year of the COVID-19 pandemic if convalescent ...

A new study estimates that thousands of lives could have been saved during the first year of the COVID-19 pandemic if convalescent plasma had been used more broadly, particularly in outpatients at ...